Title
A Safety and Efficacy Study to Evaluate Wound Healing
A Randomized, Double-blind, Vehicle-controlled, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intradermally Administered AIV001 in the Healing of Incisional Wounds
Phase
Phase 1/Phase 2Lead Sponsor
Aiviva BioPharma Inc.Study Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Wound HealIntervention/Treatment
AIV001Study Participants
16To evaluate the safety, efficacy and pharmacokinetic profile of ascending concentrations of the study medication compared with vehicle in subjects with incisional wounds
This is primarily a safety study to evaluate the safety of AIV001 when administered near incisional wounds. Exploratory efficacy measures will also be collected as well as pharmacokinetic profiles.
One side of the subject will receive 0.033% AIV001 and the other side of the subject will receive vehicle.
One side of the subject will receive 0.1% AIV001 and the other side of the subject will receive vehicle.
One side of the subject will receive 0.3% AIV001 and the other side of the subject will receive vehicle.
One side of the subject will receive 1% AIV001 and the other side of the subject will receive vehicle.
Inclusion Criteria: Eligible for an abdominoplasty Nonsmoker Fitzpatrick I-IV Weight >45Kg BMI <= 35 Exclusion Criteria: Existing scars in study area, active infection Any medical history or present conditions that may increase the risk associated with study participation or investigational product administration and, in the judgment of the Investigator, would make the subject inappropriate for entry into this study